CD8A and colorectal cancer: In breast cancer (Li L. et al., 2022) and colorectal cancer (Huang et al., 2023; Xu et al., 2022) models, GA treatment increased CD8+ T-cell infiltration several-fold and reversed T-cell exhaustion by inhibiting the PD-1/PD-L1 immune checkpoint axis.